Pretty good reason not to sign onto the WHO pandemic treaty.

Expand full comment

Great article!

This British Medical Journal opinion piece explains trials such as these.


Expand full comment

Q. How does one set out to destroy the reputation of a Nobel Prize winning drug AND kill lots of people as a result of your fraudulent conduct?

A. Like this.

Expand full comment

Dr. Meryl Nass, you are a rare bird. You are everything a doctor should be and you shine like a beacon of light on the dark state of medicine, today. Your persistent commitment to the health and wellbeing of people everywhere is like oxygen for all of us watching the field of medicine implode before our eyes. I hope other physicians as dedicated as you can find strength and comfort in each other because this is an uphill battle we can't lose.

Expand full comment

The Dark-Triad of BigGov, BigBiz, and BigMedia conspired from the start remake the world, and rewrite reality. They continue daily their ongoing assault on sovereignty and humanity; while we the people have yet to meaningfully organize against it.

Expand full comment

"it did not have signed informed consent forms for some subjects

I'd like to see correlation between missing consent forms & names of deceased.

Mass murder.

Expand full comment

The evil out there not to mention the evil being planned is absolutely unacceptable. What can we (large WE) do about it? For two years now, the avalanche of corruption and chicanery has piled higher and higher. It's time to act!

Expand full comment

They always need a "Fall guy" - first it's Lee Oswald - the "19 Arab juhadists" - the their best yet - a Virus - and now seems they've done even better ?!

with "a mathematical model"

Wasn't that what NIST used to "explain" how WTC7 went into free fall(guy?) for 2.5 seconds - "from office fires." Not that they would show anyone the program, nor the data that they used to produce a Cartoon looking nothing at all like WTC7's collapse.

And we have to be pushed around by these cunning "morons".

Expand full comment

What was the scientific basis for the FDA limiting its EUA to hospitalized patients?

Here's the March 28 EUA.

"Authorized Hydroxychloroquine Sulfate

I am authorizing use of the following hydroxychloroquine sulfate product that is distributed from

the SNS to public health authorities for response to the COVID-19 pandemic:

• FDA-approved hydroxychloroquine sulfate that is approved by FDA for other uses and

accompanied by its FDA-approved labeling and authorized Fact Sheets.

• The hydroxychloroquine sulfate must be administered by a healthcare provider pursuant

to a valid valid prescription of a licensed practitioner.

• The hydroxychloroquine sulfate may only be used to treat adult and adolescent patients

who weigh 50 kg or more hospitalized with COVID-19 for whom a clinical trial is not

available or participation is not feasible."


Where is the scientific basis for the limitation to hospitals and clinical trials? Why was outpatient treatment excluded?

Expand full comment

From https://www.nejm.org/doi/full/10.1056/NEJMoa2022926

"These findings indicate that hydroxychloroquine is not an effective treatment for hospitalized patients with Covid-19 but do not address its use as prophylaxis or in patients with less severe SARS-CoV-2 infection managed in the community."

So the NEJM research article stated that its conclusions don't apply to outpatient treatment.

Why then did so many say that HCQ didn't work at all?

Expand full comment

Systems Biological Analysis of Immune Response

to Influenza Vaccination June 1, 2021


“The last decade has witnessed tremendous progress in immunology and vaccinology,

owing to several scientific and technological breakthroughs.”

Defining Mechanisms and Correlates of Protection in Human

Influenza Challenge Studies

“The ultimate goal of systems biological studies applied to influenza research

is to further our understanding of the mechanisms of immunogenicity and

protection induced by vaccination and leverage this knowledge to develop

novel or better vaccination strategies. Ideally, the best way of achieving this

goal is to design clinical studies in which subjects who receive an influenza

vaccine can be subsequently challenged with the pathogen. Such studies would

provide us with more direct measurement of vaccine efficacy and thus be

extremely useful for the identification of biological markers that could discriminate

protected from nonprotected vaccines therefore leading to the discovery of novel

correlates of vaccine-induced protection.”

Stanford Administrative Guide

“There are times when Stanford's business activities and other conduct of its University Community members are not governed by specific laws or regulations. In these instances, rules of fairness, honesty, and respect for the rights of others will govern our conduct at all times.”


Institutions are now the breeding ground for morally delusional sociopaths with no ethical compass and no sanctity for life.

Expand full comment

The WHO Model Lists of Essential Medicines are updated every two years by the Expert Committee on Selection and Use of Essential Medicines. March 2017


General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. . Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned.

Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. This publication contains the collective views of a WHO Expert Committee and does not necessarily represent the decisions or the policies of the World Health Organization.

Printed in Italy.


19-20 MAY 2017

The first G20 Health Ministers’ Meeting was held on 5-6 November 2017, under the German presidency of the G20. The meeting was chaired by the German Federal Minister of Health Hermann Gröhe.

Berlin Declaration of the G20 Health Ministers:

Together Today for a Healthy Tomorrow - May 20, 2017


The Group of 20 is comprised of the 19 leading industrialised and emerging economies plus the EU. The G20 accounts for three quarters of global trade and two thirds of the global population. Its members are Argentina, Australia, Brazil, Canada, China, France, Germany, India, Indonesia, Italy, Japan, Mexico, Russia, Saudi Arabia, South Africa, South Korea, Turkey, the United Kingdom, the USA and the EU.


In response to the call of the World Health Organization, the Chinese government issued its national action plan to contain antimicrobial resistance (AMR) in August 2016. The ambitious five-year plan contains detailed strategies and clear targets.


As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council).

The meeting is scheduled to be held on September 13, 2017, from 9:00 a.m. to 5:00 p.m. ET, and September 14, 2017, from 9:00 a.m. to 3:00 p.m. ET.

Under Executive Order 13676, dated September 18, 2014, authority was given to the Secretary of HHS to establish the Advisory Council, in consultation with the Secretaries of Defense and Agriculture. Activities of the Advisory Council are governed by the provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees.


Expand full comment

Also, lawsuits....this one was just launched in the states...wish we could do the same here and around the world...


Expand full comment

Why do bureaucrats have bigger balls? But I get what you mean.

Expand full comment